Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

NCT01478633 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Galantamine

Sponsor

Janssen Pharmaceutical K.K.